摘要: About 50 percent of women have histologic evidence some degree fibrocystic changes in the breast. This review article describes spectrum benign breast disorders, including those that increase risk malignant disease. The authors explain evaluation and management pain, discharge, focal lesions, as well options can prevent progression to cancer.
sci-hub.se 参考文章(68)
N F Boyd, H M Jensen, G Cooke, H Lee Han, G A Lockwood, A B Miller, Mammographic densities and the prevalence and incidence of histological types of benign breast disease European Journal of Cancer Prevention. ,vol. 9, pp. 15- 24 ,(2000) , 10.1097/00008469-200002000-00003
Bruce Kessel, Premenstrual syndrome. Advances in diagnosis and treatment. Obstetrics and Gynecology Clinics of North America. ,vol. 27, pp. 625- 639 ,(2000) , 10.1016/S0889-8545(05)70160-1
H. Hamed, M. A. Chaudary, I. S. Fentiman, M. Caleffi, LHRH analogue for treatment of recurrent and refractory mastalgia. Annals of The Royal College of Surgeons of England. ,vol. 72, pp. 221- 224 ,(1990)
Sam G. Pappas, V. Craig Jordan, Chemoprevention of breast cancer: current and future prospects. Cancer and Metastasis Reviews. ,vol. 21, pp. 311- 321 ,(2002) , 10.1023/A:1021219212638
Endogenous Hormones and Breast Cancer Collaborative Group, None, Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute. ,vol. 94, pp. 606- 616 ,(2002) , 10.1093/JNCI/94.8.606
Celia Byrne, Catherine Schairer, Louise A. Brinton, John Wolfe, Navin Parekh, Martine Salane, Christine Carter, Robert Hoover, Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes & Control. ,vol. 12, pp. 103- 110 ,(2001) , 10.1023/A:1008935821885
Martin J. Yaffe, David L. Tritchler, Norman F. Boyd, Gina A. Lockwood, Jeff W. Byng, Mammographic densities and breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 7, pp. 1133- 1144 ,(1998)
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. The Lancet. ,vol. 360, pp. 817- 824 ,(2002) , 10.1016/S0140-6736(02)09962-2
M Miers, C A Gateley, R E Mansel, L E Hughes, Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. Journal of the Royal Society of Medicine. ,vol. 85, pp. 12- 15 ,(1992) , 10.1177/014107689208500105
John Feightner, Mark Levine, Jean-Marie Moutquin, Ruth Walton, Chemoprevention of breast cancer: A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer Canadian Medical Association Journal. ,vol. 164, pp. 1681- 1690 ,(2001)